Jump to content
Powered by

LifeCodexx Appoints Head of Commercial Operations

Dr. Martin Burow, a proven expert in the field of prenatal diagnostics, has joined the LifeCodexx team as Head of Commercial Operations.

LifeCodexx AG, a GATC Subsidiary, announces that Dr. Martin Burow, a proven expert in the field of prenatal diagnostics, has joined its team as Head of Commercial Operations. Until the middle of 2010 Dr. Burow was Sales Manager Asia – Pacific at Brahms AG, which was taken over by ThermoFisher Scientific in 2009. He was responsible for the complete diagnostics product range from prenatal and thyroidal through to sepsis diagnostics.

“Now that the development of our first test for non-invasive pre-natal diagnostics using Next Generation Sequencing technologies is entering its final phase, we are delighted to be joined by Dr. Burow, an experienced sales expert in the field of prenatal diagnostics. Dr. Burow will energetically assist us to quickly and efficiently establish strategic access to various European key markets,” said Dr. Michael Lutz, CEO of LifeCodexx AG.

“I see great potential for the non-invasive sequencing method for prenatal diagnostics developed by LifeCodexx AG. This technology will not only make it possible to provide a risk assessment during the early phase of pregnancy, but also to carry out a real diagnosis and minimize the risk to the health of the mother and the growing foetus associated with invasive methods,“ added Dr. Martin Burow.

Contact:
LifeCodexx AG
Dr. Michael Lutz
Chief Executive Officer
e-mail: m.lutz(at)lifecodexx.com
phone: +49 (0) 7531 81 60 15

Website address: https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-appoints-head-of-commercial-operations